Oman Journal of Ophthalmology

LETTER TO THE EDITOR
Year
: 2012  |  Volume : 5  |  Issue : 1  |  Page : 68-

Intravitreal bevacizumab and diabetic papillopathy with macular edema


Beuy Joob1, Viroj Wiwanitkit2,  
1 Sanitation Medical Academic Center, Bangkok, Thailand
2 Wiwanitkit House, Bangkhae, Bangkok, Thailand

Correspondence Address:
Beuy Joob
Sanitation Medical Academic Center, Bangkok
Thailand




How to cite this article:
Joob B, Wiwanitkit V. Intravitreal bevacizumab and diabetic papillopathy with macular edema.Oman J Ophthalmol 2012;5:68-68


How to cite this URL:
Joob B, Wiwanitkit V. Intravitreal bevacizumab and diabetic papillopathy with macular edema. Oman J Ophthalmol [serial online] 2012 [cited 2022 Jul 1 ];5:68-68
Available from: https://www.ojoonline.org/text.asp?2012/5/1/68/94797


Full Text

Sir,

The recent publication on intravitreal bevacizumab and diabetic papillopathy with macular edema is very interesting. [1] Al-Hinai et al., conclude that "bevacizumab is a useful treatment in diabetic papillopathy by shortening the duration of the course of the disease". [1] It might seem that this treatment is effective. However, there are many things to be discussed. Experience of the practitioner is very important and there are some reports on complications of this practice. [2],[3] The observation on systemic change corresponding to the use of bevacizumab is also required. [4] Finally, although bevacizuman is more effective than simple triamcinolone acetonide, [5] the question of cost needs to be researched.

References

1Al-Hinai AS, Al-Abri MS, Al-Hajri RH. Diabetic papillopathy with macular edema treated with intravitreal bevacizumab. Oman J Ophthalmol 2011;4:135-8.
2Arevalo JF, Sanchez JG, Saldarriaga L, Berrocal MH, Fromow-Guerra J, Morales-Canton V, et al.; Pan American Collaborative Retina Study Group. Retinal detachment after bevacizumab. Ophthalmology 2011;118:2304.e3-7.
3Jamrozy-Witkowska A, Kowalska K, Jankowska-Lech I, Terelak-Borys B, Nowosielska A, Grabska-Liberek I. Complications of intravitreal injections-Own experience. Klin Oczna 2011;113:127-31.
4Matsuyama K, Ogata N, Matsuoka M, Wada M, Nishimura T, Takahashi K. Source Effects of intravitreally injected bevacizumab on vascular endothelial growth factor in fellow eyes. J Ocul Pharmacol Ther 2011;27:379-83.
5Song JH, Lee JJ, Lee SJ. Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema. Korean J Ophthalmol 2011;25:156-60.